Hyperfine, Inc.

HealthCor Catalio Acquisition Corp., trading under the ticker HCAQ, was a blank-check company sponsored by HealthCor Catalio Management, LLC, a partnership between healthcare-focused investor HealthCor Partners and life-sciences venture firm Catalio Capital Management. The SPAC completed its initial public offering in February 2021 and targeted opportunities in the healthcare technology sector. HCAQ subsequently entered into a business combination agreement with Hyperfine, Inc., a medical device company known for developing portable, low-field MRI technology aimed at broadening patient access to neuroimaging. The de-SPAC transaction closed in late 2021, with the combined company listing on Nasdaq under the ticker HYPR. Visit SpacDesk and sign up for full data, filings, and deal timelines on HCAQ and hundreds of other SPAC transactions.